Bird A - Search Results

1

Efficacy of an adeno-associated virus 8-pseudotyped vector in glycogen storage disease type II.

Sun B, Zhang H, Franco LM, Young SP, Schneider A, Bird A, Amalfitano A, Chen YT, Koeberl DD. Sun B, et al. Among authors: bird a. Mol Ther. 2005 Jan;11(1):57-65. doi: 10.1016/j.ymthe.2004.10.004. Mol Ther. 2005. PMID: 15585406 Free article.

2

Long-term correction of glycogen storage disease type II with a hybrid Ad-AAV vector.

Sun BD, Chen YT, Bird A, Amalfitano A, Koeberl DD. Sun BD, et al. Among authors: bird a. Mol Ther. 2003 Feb;7(2):193-201. doi: 10.1016/s1525-0016(02)00055-2. Mol Ther. 2003. PMID: 12597907 Free article.

3

Packaging of an AAV vector encoding human acid alpha-glucosidase for gene therapy in glycogen storage disease type II with a modified hybrid adenovirus-AAV vector.

Sun B, Chen YT, Bird A, Xu F, Hou YX, Amalfitano A, Koeberl DD. Sun B, et al. Among authors: bird a. Mol Ther. 2003 Apr;7(4):467-77. doi: 10.1016/s1525-0016(03)00022-4. Mol Ther. 2003. PMID: 12727109 Free article.

4

Correction of glycogen storage disease type II by an adeno-associated virus vector containing a muscle-specific promoter.

Sun B, Zhang H, Franco LM, Brown T, Bird A, Schneider A, Koeberl DD. Sun B, et al. Among authors: bird a. Mol Ther. 2005 Jun;11(6):889-98. doi: 10.1016/j.ymthe.2005.01.012. Mol Ther. 2005. PMID: 15922959 Free article.

5

Evasion of immune responses to introduced human acid alpha-glucosidase by liver-restricted expression in glycogen storage disease type II.

Franco LM, Sun B, Yang X, Bird A, Zhang H, Schneider A, Brown T, Young SP, Clay TM, Amalfitano A, Chen YT, Koeberl DD. Franco LM, et al. Among authors: bird a. Mol Ther. 2005 Nov;12(5):876-84. doi: 10.1016/j.ymthe.2005.04.024. Epub 2005 Jul 6. Mol Ther. 2005. PMID: 16005263 Free article.

6

Enhanced efficacy of an AAV vector encoding chimeric, highly secreted acid alpha-glucosidase in glycogen storage disease type II.

Sun B, Zhang H, Benjamin DK Jr, Brown T, Bird A, Young SP, McVie-Wylie A, Chen YT, Koeberl DD. Sun B, et al. Among authors: bird a. Mol Ther. 2006 Dec;14(6):822-30. doi: 10.1016/j.ymthe.2006.08.001. Epub 2006 Sep 20. Mol Ther. 2006. PMID: 16987711 Free PMC article.

7

Enhanced response to enzyme replacement therapy in Pompe disease after the induction of immune tolerance.

Sun B, Bird A, Young SP, Kishnani PS, Chen YT, Koeberl DD. Sun B, et al. Among authors: bird a. Am J Hum Genet. 2007 Nov;81(5):1042-9. doi: 10.1086/522236. Epub 2007 Sep 21. Am J Hum Genet. 2007. PMID: 17924344 Free PMC article.

8

AAV vector-mediated reversal of hypoglycemia in canine and murine glycogen storage disease type Ia.

Koeberl DD, Pinto C, Sun B, Li S, Kozink DM, Benjamin DK Jr, Demaster AK, Kruse MA, Vaughn V, Hillman S, Bird A, Jackson M, Brown T, Kishnani PS, Chen YT. Koeberl DD, et al. Among authors: bird a. Mol Ther. 2008 Apr;16(4):665-72. doi: 10.1038/mt.2008.15. Epub 2008 Mar 11. Mol Ther. 2008. PMID: 18362924 Free article.

9

Correction of multiple striated muscles in murine Pompe disease through adeno-associated virus-mediated gene therapy.

Sun B, Young SP, Li P, Di C, Brown T, Salva MZ, Li S, Bird A, Yan Z, Auten R, Hauschka SD, Koeberl DD. Sun B, et al. Among authors: bird a. Mol Ther. 2008 Aug;16(8):1366-71. doi: 10.1038/mt.2008.133. Epub 2008 Jun 17. Mol Ther. 2008. PMID: 18560415 Free PMC article.

10

Impaired clearance of accumulated lysosomal glycogen in advanced Pompe disease despite high-level vector-mediated transgene expression.

Sun B, Zhang H, Bird A, Li S, Young SP, Koeberl DD. Sun B, et al. Among authors: bird a. J Gene Med. 2009 Oct;11(10):913-20. doi: 10.1002/jgm.1372. J Gene Med. 2009. PMID: 19621331 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,445 results

Search Page

Filters